Logo image of BMY

BRISTOL-MYERS SQUIBB CO (BMY) Stock Price, Quote, News and Overview

NYSE:BMY - New York Stock Exchange, Inc. - US1101221083 - Common Stock - Currency: USD

46.92  -0.71 (-1.49%)

After market: 47.05 +0.13 (+0.28%)

BMY Quote, Performance and Key Statistics

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (7/3/2025, 7:05:26 PM)

After market: 47.05 +0.13 (+0.28%)

46.92

-0.71 (-1.49%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High63.33
52 Week Low39.5
Market Cap95.49B
Shares2.04B
Float2.03B
Yearly Dividend2.42
Dividend Yield5.32%
PE6.39
Fwd PE7.63
Earnings (Next)07-31 2025-07-31/bmo
IPO07-05 1929-07-05


BMY short term performance overview.The bars show the price performance of BMY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

BMY long term performance overview.The bars show the price performance of BMY in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20 -30

The current stock price of BMY is 46.92 USD. In the past month the price decreased by -2.15%. In the past year, price increased by 18.31%.

BRISTOL-MYERS SQUIBB CO / BMY Daily stock chart

BMY Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 56.73 739.87B
JNJ JOHNSON & JOHNSON 15.52 375.37B
NVO NOVO-NORDISK A/S-SPONS ADR 18.69 307.35B
NVS NOVARTIS AG-SPONSORED ADR 14.67 240.76B
AZN ASTRAZENECA PLC-SPONS ADR 15.78 215.32B
MRK MERCK & CO. INC. 10.39 203.22B
PFE PFIZER INC 7.91 144.29B
SNY SANOFI-ADR 10.55 117.55B
GSK GSK PLC-SPON ADR 8.48 77.37B
ZTS ZOETIS INC 26.44 70.87B
TAK TAKEDA PHARMACEUTIC-SP ADR 63.92 47.92B
HLN HALEON PLC-ADR 20.5 46.12B

About BMY

Company Profile

BMY logo image Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees. The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.

Company Info

BRISTOL-MYERS SQUIBB CO

Route 206 And Province Line Road

Princeton NEW JERSEY 10016 US

CEO: Giovanni Caforio

Employees: 34100

BMY Company Website

BMY Investor Relations

Phone: 16092524621

BRISTOL-MYERS SQUIBB CO / BMY FAQ

What is the stock price of BRISTOL-MYERS SQUIBB CO today?

The current stock price of BMY is 46.92 USD. The price decreased by -1.49% in the last trading session.


What is the ticker symbol for BRISTOL-MYERS SQUIBB CO stock?

The exchange symbol of BRISTOL-MYERS SQUIBB CO is BMY and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is BMY stock listed?

BMY stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for BRISTOL-MYERS SQUIBB CO stock?

32 analysts have analysed BMY and the average price target is 55.96 USD. This implies a price increase of 19.28% is expected in the next year compared to the current price of 46.92. Check the BRISTOL-MYERS SQUIBB CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BRISTOL-MYERS SQUIBB CO worth?

BRISTOL-MYERS SQUIBB CO (BMY) has a market capitalization of 95.49B USD. This makes BMY a Large Cap stock.


How many employees does BRISTOL-MYERS SQUIBB CO have?

BRISTOL-MYERS SQUIBB CO (BMY) currently has 34100 employees.


What are the support and resistance levels for BRISTOL-MYERS SQUIBB CO (BMY) stock?

BRISTOL-MYERS SQUIBB CO (BMY) has a resistance level at 47.3. Check the full technical report for a detailed analysis of BMY support and resistance levels.


Is BRISTOL-MYERS SQUIBB CO (BMY) expected to grow?

The Revenue of BRISTOL-MYERS SQUIBB CO (BMY) is expected to decline by -3.38% in the next year. Check the estimates tab for more information on the BMY EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BRISTOL-MYERS SQUIBB CO (BMY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BRISTOL-MYERS SQUIBB CO (BMY) stock pay dividends?

BRISTOL-MYERS SQUIBB CO (BMY) has a dividend yield of 5.32%. The yearly dividend amount is currently 2.42. Check the full fundamental report for a detailed analysis of BMY dividend history, reliability and sustainability.


When does BRISTOL-MYERS SQUIBB CO (BMY) report earnings?

BRISTOL-MYERS SQUIBB CO (BMY) will report earnings on 2025-07-31, before the market open.


What is the Price/Earnings (PE) ratio of BRISTOL-MYERS SQUIBB CO (BMY)?

The PE ratio for BRISTOL-MYERS SQUIBB CO (BMY) is 6.39. This is based on the reported non-GAAP earnings per share of 7.34 and the current share price of 46.92 USD. Check the full fundamental report for a full analysis of the valuation metrics for BMY.


What is the Short Interest ratio of BRISTOL-MYERS SQUIBB CO (BMY) stock?

The outstanding short interest for BRISTOL-MYERS SQUIBB CO (BMY) is 1.65% of its float. Check the ownership tab for more information on the BMY short interest.


BMY Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BMY Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BMY. BMY has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BMY Financial Highlights

Over the last trailing twelve months BMY reported a non-GAAP Earnings per Share(EPS) of 7.34. The EPS increased by 599.05% compared to the year before.


Industry RankSector Rank
PM (TTM) 11.38%
ROA 5.86%
ROE 31.16%
Debt/Equity 2.67
Chartmill High Growth Momentum
EPS Q2Q%140.91%
Sales Q2Q%-5.6%
EPS 1Y (TTM)599.05%
Revenue 1Y (TTM)4.62%

BMY Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 68% to BMY. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 499.13% and a revenue growth -3.38% for BMY


Ownership
Inst Owners82.11%
Ins Owners0.03%
Short Float %1.65%
Short Ratio2.19
Analysts
Analysts67.5
Price Target55.96 (19.27%)
EPS Next Y499.13%
Revenue Next Year-3.38%